Salarius: Q4 Earnings Snapshot

HOUSTON (AP) _ Salarius Pharmaceuticals, Inc. (SLRX) on Thursday reported a loss of $2.2 million in its fourth quarter.

The Houston-based company said it had a loss of 10 cents per share.

The biotech drug developer posted revenue of $1.5 million in the period.

For the year, the company reported that its loss widened to $7.7 million, or 50 cents per share. Revenue was reported as $5.2 million.

In the final minutes of trading on Thursday, the company's shares hit $1.50. A year ago, they were trading at 66 cents.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SLRX at https://www.zacks.com/ap/SLRX